FDA Adverse Event Malfunction Summary report: N

ANTI-JKB BIOCLONE

MDR report key: 4361572 · Received December 24, 2014

Report

Report Number
2250051-2014-00128
Event Type
Malfunction
Date Received
December 24, 2014
Date of Event
March 21, 2013
Report Date
December 24, 2014
Manufacturer
ORTHO CLINICAL DIAGNOSTICS
Product Code
KSZ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

OCD PERFORMED BATCH REVIEW AND COMPLAINT REVIEW BY LOT. ALL RESULTS WERE SATISFACTORY. LOT EXPIRED ON 20NOV2013 SO NO RETAIN TESTING WAS POSSIBLE. SAMPLE WAS NOT AVAILABLE TO BE SENT TO OCD FOR FURTHER INVESTIGATION. (B)(4). LOT EXPIRED ON 20NOV2013 SO NO RETAIN TESTING IS POSSIBLE.

Description of Event or Problem · 1

CUSTOMER REPORTED ONE PATIENT WAS TESTED ON (B)(6) 2013 WITH ANTI-JKB LOT# JBB420A EXP 20NOV2013 AND THE RESULTS WERE LATER DETERMINED TO BE FALSE POSITIVE. IN 2014, CUSTOMER USED TWO MOLECULAR TESTS TO DETERMINE THAT THE PATIENT IS ACTUALLY HOMOZYGOUS FOR THE JKA ANTIGEN AND NEGATIVE FOR THE JKB ANTIGEN. CUSTOMER IS REPORTING RESULTS AFTER INVESTIGATION WAS PERFORMED AS A RESULT OF MOLECULAR TESTING. CUSTOMER BELIEVES THIS ISSUE TO BE RELATED TO THE PATIENT'S UNIQUE ANTIGEN EXPRESSION, NOT DUE TO A PRODUCT ISSUE. ALL QC TESTING DONE WITH ANTI-JKB HAD PASSED AS EXPECTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
850731 ANTI-JKB BIOCLONE ANTISERA FOR ANTIGEN TYPING KSZ ORTHO CLINICAL DIAGNOSTICS JBB420A

Patients

Seq Age Sex Outcome Treatment
1